Tenofovir: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk mNo edit summary |
imported>David E. Volk m (→External links) |
||
Line 17: | Line 17: | ||
== External links == | == External links == | ||
* {{DailyMed}} | * {{DailyMed}} | ||
* | * {{MedMaster}} | ||
* {{DrugBank}} |
Revision as of 11:42, 5 March 2008
Tenofovir is a nucleotide analog reverse transcritase inhibitor (nRTI) antiviral drug used to treat HIV/AIDS and is in clinical trials for treatment of hepatitis B infection. The triphosphate from of the drug competes with the natural DNA nucleotide deoxyadenosine triphosphate (dATP) during DNA formation and it acts as a DNA chain terminator once incorporated because it lacks the normal deoxyribose sugar needed for connecting to the next DNA base.
Synonyms and brand names
Synonyms
- Tenofovir disoproxil
- Tenofovir disoproxil fumarate
- D,L-Tenofovir
- TDF
- PMPA
Brand Names
- Apropovir
- Viread
External links
- Tenofovir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Template:MedMaster
- Template:DrugBank